NCT00197743View on ClinicalTrials.gov

Trial of Vitamins in HIV Progression and Transmission

PHASE3CompletedINTERVENTIONAL
Enrollment

1,085

Participants

Timeline

Start Date

April 30, 1995

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
HIV InfectionsDisease Transmission, Vertical
Interventions
DIETARY_SUPPLEMENT

Vitamin A + Beta Carotene

one daily oral dose of 30 mg beta-carotene + 5000 IU preformed vitamin A

DIETARY_SUPPLEMENT

Multivitamins

one daily oral dose of 20 mg thiamine (vitamin B-1), 20 mg riboflavin (vitamin B-2), 25 mg vitamin B-6, 100 mg niacin, 50 ug cobalamin (vitamin B-12), 500 mg vitamin C, 30 mg vitamin E, and 0.8 mg folic acid

OTHER

Placebo

Placebo pill

Trial Locations (1)

02115

Harvard School of Public Health, Boston

All Listed Sponsors
collaborator

Muhimbili University of Health and Allied Sciences

OTHER

lead

Harvard School of Public Health (HSPH)

OTHER

NCT00197743 - Trial of Vitamins in HIV Progression and Transmission | Biotech Hunter | Biotech Hunter